Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary Kay Koenig

Showing results (31-40 of 82) with videos related to

Pageof 9
Sort By:
Drugs in R&D|September 1, 2012
Topical rapamycin therapy to alleviate the cutaneous manifestations of tuberous sclerosis complex: a double-blind, randomized, controlled trial to evaluate the safety and efficacy of topically applied rapamycinMary Kay Koenig, Adelaide A Hebert, Joan Roberson, et al.
Journal of Pediatric Gastroenterology and Nutrition|March 23, 2012
Impaired gastric emptying and small bowel transit in children with mitochondrial disordersJatinder Bhardwaj, David Q Wan, Mary Kay Koenig, et al.
Journal of Genetic Counseling|August 14, 2017
Attitudes of Individuals with Gaucher Disease toward Substrate Reduction TherapiesVictoria F Wagner, Hope Northrup, S Shahrukh Hashmi, et al.
Molecular Genetics & Genomic Medicine|May 9, 2020
Two different genetic etiologies for tuberous sclerosis complex (TSC) in a single familyKate Mowrey, Mary Kay Koenig, Charles A Szabo, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 8, 2019
Vulnerability of pediatric patients with mitochondrial disease to vaccine-preventable diseasesShannon K Kruk, Susan E Pacheco, Mary Kay Koenig, et al.
JIMD Reports|January 13, 2023
Use of Elamipretide in patients assigned treatment in the compassionate use program: Case series in pediatric patients with rare orphan diseasesMary Kay Koenig, Sam Nick Russo, Kim L McBride, et al.
The Open Respiratory Medicine Journal|August 13, 2013
Decreased exhaled nitric oxide levels in patients with mitochondrial disordersRicardo A Mosquera, Cheryl L Samuels, Tomika S Harris, et al.
BMC Neurology|May 19, 2026
Early neurodevelopmental outcomes in a child with tuberous sclerosis complex treated with everolimus and vigabatrinSarah Ml Wilson, Megan Samuels, Luana Pimentel, et al.
Pediatric Neurology|October 22, 2013
Subependymal giant cell astrocytoma: diagnosis, screening, and treatment. Recommendations from the International Tuberous Sclerosis Complex Consensus Conference 2012Jonathan Roth, E Steve Roach, Ute Bartels, et al.
Seizure|February 9, 2010
POLG DNA testing as an emerging standard of care before instituting valproic acid therapy for pediatric seizure disordersRussell P Saneto, Inn-Chi Lee, Mary Kay Koenig, et al.
Pageof 9

Showing results (31-40 of 82) with videos related to

Sort By:
Pageof 9
Drugs in R&D|September 1, 2012
Topical rapamycin therapy to alleviate the cutaneous manifestations of tuberous sclerosis complex: a double-blind, randomized, controlled trial to evaluate the safety and efficacy of topically applied rapamycinMary Kay Koenig, Adelaide A Hebert, Joan Roberson, et al.
Journal of Pediatric Gastroenterology and Nutrition|March 23, 2012
Impaired gastric emptying and small bowel transit in children with mitochondrial disordersJatinder Bhardwaj, David Q Wan, Mary Kay Koenig, et al.
Journal of Genetic Counseling|August 14, 2017
Attitudes of Individuals with Gaucher Disease toward Substrate Reduction TherapiesVictoria F Wagner, Hope Northrup, S Shahrukh Hashmi, et al.
Molecular Genetics & Genomic Medicine|May 9, 2020
Two different genetic etiologies for tuberous sclerosis complex (TSC) in a single familyKate Mowrey, Mary Kay Koenig, Charles A Szabo, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 8, 2019
Vulnerability of pediatric patients with mitochondrial disease to vaccine-preventable diseasesShannon K Kruk, Susan E Pacheco, Mary Kay Koenig, et al.
JIMD Reports|January 13, 2023
Use of Elamipretide in patients assigned treatment in the compassionate use program: Case series in pediatric patients with rare orphan diseasesMary Kay Koenig, Sam Nick Russo, Kim L McBride, et al.
The Open Respiratory Medicine Journal|August 13, 2013
Decreased exhaled nitric oxide levels in patients with mitochondrial disordersRicardo A Mosquera, Cheryl L Samuels, Tomika S Harris, et al.
BMC Neurology|May 19, 2026
Early neurodevelopmental outcomes in a child with tuberous sclerosis complex treated with everolimus and vigabatrinSarah Ml Wilson, Megan Samuels, Luana Pimentel, et al.
Pediatric Neurology|October 22, 2013
Subependymal giant cell astrocytoma: diagnosis, screening, and treatment. Recommendations from the International Tuberous Sclerosis Complex Consensus Conference 2012Jonathan Roth, E Steve Roach, Ute Bartels, et al.
Seizure|February 9, 2010
POLG DNA testing as an emerging standard of care before instituting valproic acid therapy for pediatric seizure disordersRussell P Saneto, Inn-Chi Lee, Mary Kay Koenig, et al.
Pageof 9